Bio-Tech Specialty has historically generated a return on equity of 16% on its investment projects. Glven the risk associated with some of the new product development, market players are expected to demand a return of 15% on the stock. The firm has decided to maintain a plowback ratio of 30% for the coming year. Earnings for the current year are projected at $4.00. A. the stock should sell at a price of and a P/E ratio of B. the present value of growth oppol C. if Bio-Tech decides to re-invest only 20% of its earnings, the P/E ratio will be and the PVGO will be $ D. As an equity analyst who closely follows this Tech company, you would suggest that the Board its dividend payout ratio